Details for Patent: 6,287,599
✉ Email this page to a colleague
Summary for Patent: 6,287,599
Title: | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
Abstract: | A pharmaceutical composition comprising at least one pharmaceutically active agent that is pH dependent, at least one non-pH dependent sustained release agent, and at least one pH dependent agent that increases the dissolution rate of the at least one pharmaceutically active agent at a pH in excess of 5.5. Such compositions have minimized pH-dependent dissolution profiles or pH-independent dissolution profiles. |
Inventor(s): | Burnside; Beth A. (Brookeville, MD), Chang; Rong-Kun (Rockville, MD), Guo; Xiaodi (Derwood, MD) |
Assignee: | Shire Laboratories, Inc. (Rockville, MD) |
Application Number: | 09/741,548 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,287,599 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Formulation; |
Drugs Protected by US Patent 6,287,599
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,287,599
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2002249881 | ⤷ Sign Up | |||
Canada | 2432178 | ⤷ Sign Up | |||
Cyprus | 1116023 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |